Patent ID: 7871606

Claim:
A method for treating cancer, the method comprising: (a) stimulating peripheral-blood mononuclear cells (PBMC) with immobilized anti-CD3 antibodies to produce primary stimulated PBMC; (b) adding naïve PBMC to the primary stimulated PBMC; (c) incubating the naïve PBMC added in step (b) in the presence of the primary stimulated PBMC produced in step (a) to stimulate the naïve PBMC by the primary stimulated PBMC, thereby obtaining PBMC that have been stimulated via cascade priming of steps (a) to (c) (CAPRI cells); and; (d) administering the CAPRI cells into a cancer patient, wherein the primary stimulation of step (a) and/or the stimulation of naïve PBMC of step (c) occurs in the presence of at least one cytokine selected from the group of interleukin-2 (IL-2), interleukin-4 (IL-4), and interferon γ (IFN-γ).